Expression of apoptosis-related proteins in rat with induced colitis

International Journal of Colorectal Disease

Volumn 19, Issue 5, 2004, Pages 451-460

  D'Argenio, Giuseppe ^a   Farrace, Maria Grazia ^b   Cosenza, Vittorio ^a   De Ritis, Francesca ^a   Della Valle, Nicola ^a   Manguso, Francesco ^a   Piacentini, Mauro ^b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Apoptosis markers; Apoptosis related proteins; Induced colitis; Rats

Indexed keywords

FAS ANTIGEN; FAS LIGAND; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; PROTEIN P53; TRINITROBENZENESULFONIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL LINE; CHRONIC INFLAMMATION; COLON BIOPSY; COLON INJURY; COLON MUCOSA; CONTROLLED STUDY; DISEASE SEVERITY; ENTERITIS; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; GENE ACTIVATION; HISTOPATHOLOGY; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; MALE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROTEIN EXPRESSION; RAT; TISSUE HOMOGENATE; ULCERATIVE COLITIS;

EID: 4444221500     PISSN: 01791958     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00384-004-0585-5     Document Type: Article

References (49)

1. Thompson CB (1995) Apoptosis in pathogenesis and treatment of disease. Science 267:1456-1462
2. Cummings MC, Winterford CM, Walker NI (1997) Apoptosis. Am J Surg Pathol 21:88-101
3. Watson AJM (1995) Necrosis and apoptosis in the gastrointestinal tract. Gut 37:165-167
4. Que FG, Gores GJ (1996) Cell death by apoptosis: basic concepts and disease relevance for the gastroenterologist. Gastroenterology 110:1238-1243
5. Taylor CT, Dzus AL, Colgan SP (1998) Autocrine regulation of epithelial permeability by hypoxia: role for polarized release of tumor necrosis factor α. Gastroenterology 114:657-668
6. Schmitz H, Barmeyer C, Fromm M, Runkel N, Foss HD, Bentzel CJ, et al (1999) Altered tight junction structure contributes to the impaired epithelial barrier function in ulcerative colitis. Gastroenterology 116:301-309
7. Hond ED, Hiele M, Evenepoel P, Peeters M, Ghoos Y, Rutgeerts P (1998) In vivo butyrate metabolism and colonic permeability in extensive ulcerative colitis. Gastroenterology 115:584-590
8. Strater J, Wellish I, Riedl S, Walczak H, Koretz K, Tandara A, et al (1997) CD95 (APO-1/Fas) mediated apoptosis in colon epithelial cells: a possible role in ulcerative colitis. Gastroenterology 113:160-167
9. Ueyama H, Kiyohara T, Sawada N, Isozaki K, Kitamura S, Kondo S, et al (1998) High Fas ligand expression on lymphocytes in lesion of ulcerative colitis. Gut 43:48-55
10. Yonehara S, Ishii A, Yonehara MA (1989) Cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J Exp Med 169:1747-1756
11. Itoh H, Yonehara S, Ishii A, Yonehara M, Mizushima S, Sameshima M, et al (1991) The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66:233-243
12. Nagata S, Golstein P (1995) The Fas death factor. Science 267:1449-1456
13. Suda T, Takahashi T, Golstein P, Nagata S (1993) Molecular cloning and expression of the Fas ligand: a novel member of the tumor necrosis factor family. Cell 75:1169-1178
14. Suda T, Okazaki T, Naito Y, Yojota T, Arai N, Ozaki S, et al (1995) Expression of the Fas ligand in cells of T cell leneage. J Immunol 154:3806-3813
15. Arase H, Arase N, Saito T (1995) Fas-mediated cytotoxicity by freshly isolated natural killer cells. J Exp Med 181:1235-1238
16. Leithauser F, Dhein J, Mechtersheimer G, Koretz K, Bruderlein S, Henne C, et al (1993) Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells. Lab Invest 69:415-429
17. Moller P, Koretz K, Leithauser F, Bruderlein S, Henne C, Quentmeier A, et al (1994) Expression of APO-1 (CD95), a member of the NGF-TNF receptor superfamily, in normal and neoplastic colon epithelium. Int J Cancer 57:371-377
18. Bennett MW, O'Connell J, O'Sullivan GC, Collins JK, Shanahan F (1998) Altered expression of Fas ligand by colonic epithelium in Crohn's disease and ulcerative colitis. Gastroenterology 114:A929
19. Messmer UK, Ankarkrona N, Nicotera P, Brune B (1994) p53expression in nitric oxide-induced apoptosis. FEBS Lett 355:23-26
20. Miyashita T, Krajewski S, Krajewska M, Wang HG, Lin HK, Liebermann DA, Hoffman B, Reed JC (1994) Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 9:1799-1805
21. Krishna M, Woda B, Savas L, Baker S, Banner B (1995) Expression of p53 antigen in inflamed and regenerated mucosa in ulcerative colitis and Crohn's disease. Modern Pathol 8:654-657
22. Kroemer G (1997) The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nat Med 3:614-620
23. Melino G, Piacentini M (1998) "Tissue" transglutaminase in cell death: a down stream or a multifunctional upstream effector? FEBS Lett 430:59-63
24. Piacentini M, Farrace MG, Hassan C, Serafini B, Autuori F (1999) "Tissue" transglutaminase release from apoptotic cells into extracellular matrix during human liver fibrogenesis. J Pathol 189:92-98
25. Morris GP, Beck PL, Herridge MS, Depew WT, Szewczuk MR, Wallace JL (1989) Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 96:795-803
26. D'Argenio G, Sorrentini I, Cosenza V, Gatto A, Iovino P, D'Armiento EP, et al (1992) Serum and tissue transglutaminase correlates with the severity of inflammation in induced colitis in the rat. Scand J Gastroenterol 27:111-114
27. Lorand L, Campbell-Wilkes LK, Cooperstein L (1972) A filter paper assay for transamidating enzymes using radioactive amine substrates. Anal Biochem 50:623-631
28. D'Argenio, G, Cosenza V, Sorrentini I, De Ritis F, Gatto A, Delle Cave M, et al (1994) Butyrate, mesalamine, and factor XIII in experimental colitis in the rat: effects on transglutaminase activity. Gastroenterology 106:399-404
29. Gavrieli Y, Sherman Y, Shmuel A. Ben Sasson (1992) Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119:493-501
30. Piacentini M, Fesus L, Farrace MG, Ghibelli L, Piredda L, Melino G (1991) The expression of tissue transglutaminase in two human cancer cell lines is related with the programmed cell death (apoptosis). Eur Cell Biol 54:246-254
31. Lowin Bhahne M, Mattman C, et al (1994) Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways. Nature 370:650-652
32. Laster SM, Wood JD; Gooding LR (1988) Tumor necrosis factor can induce both apoptosic and necrotic forms of cells. J Immunol 141:221-227
33. Vetuschi A, Latella G, Sferra R, Caprilli R, Gaudio E (2002) Increased proliferation and apoptosis of colonic epithelial cells in dextran sulfate sodium-induced colitis in rats. Dig Dis Sci 47:1447-1457
34. Middleton SJ, Shorthouse M, Hunter JO (1993) Increased nitric oxide synthesis in ulcerative colitis. Lancet 341:465-466
35. Lundberg JON, Hellstrom PM, Lundberg JM (1994) Greatly increased luminal nitric oxide in ulcerative colitis. Lancet 344:1673-1674
36. Loguercio C, D'Argenio G, Delle Cave M, Cosenza V, Della Valle N, Mazzacca G, et al (1996) Direct evidence of oxidative damage in acute and chronic phases of experimental colitis. Dig Dis Sci 41:1204-1211
37. Wink DA, Kasprzac KS, Maragos CM (1991) DANN-deaminating ability and genotoxicity of nitric oxide and its progenitors. Science 254:1001-1003
38. Nguyen T, Brunson D, Crespi CL (1992) DNA damage and mutation in human cells exposed to nitric oxide in vitro. Proc Natl Acad Sci USA 89:3030-3034
39. Piacentini M, Autuori F, Dini L (1991) Tissue transglutaminase is specifically expressed in neonatal rat liver cells undergoing apoptosis upon epidermal growth factor-stimulation. Cell Tissue Res 263:227-235
40. Folk JE (1980) Transglutaminases. Annu Rev Biochem 49:517-531
41. Oliviero S, Amendola A, Di Sano F (1997) Tissue transglutaminase-dependent post-translational modification of the retinoblastoma gene product in promonocytic cells undergoing apoptosis. Mol Cell Biol 17:6040-6048
42. Fesus L, Davies PJA, Piacentini M (1991) Apoptosis: molecular mechanism of programmed cell death. Eur J Cell Biol 56:170-177
43. Fesus L, Thomazy V, Autuori F, Cerù MP, Tarcsa E, Piacentini M (1989) Apoptotic hepatocytes become insoluble in detergents and chaotrophic agents as a result of transglutaminase action. FEBS Lett 245:150-154
44. Savill J, Fadok V, Henson Phaslett C (1993) Phagocyte recognition of cells undergoing apoptosis. Immunol Today 14:131-136
45. Arends MJ, Wjllie AH (1991) Apoptosis. Mechanism and role in pathology. Int Rev Exp Pathol 32:223-254
46. D'Argenio G, Biancone L, Cosenza V, Della Valle N, D'Armiento FP, Boirivant M, et al (1995) Transglutaminases in Crohn's disease. Gut 37:690-695
47. D'Argenio G, Cosenza V, Riegler G, Della Valle N, De Ritis F, Mazzacca G, Gruppo Italiano per lo Studio del Colon e retto (GISC) (2001) Serum transglutaminase correlates with endoscopic and histopathologic grading in patients with ulcerative colitis. Dig Dis Sci 46:649-657
48. D'Argenio G, Grossman A, Cosenza V, Della Valle N, Mazzacca M, Bishop PD (2000) Recombinant factor XIII improves experimental colitis in rats. Dig Dis Sci 45:987-997
49. D'Argenio G, Iovino P, Cosenza V, Della Valle V, De Ritis F, Mazzacca G (2001) Factor XIII improves gastric stress lesions in rats. Digestion 63:220-228